Industries > Pharma > Global Drug Discovery Outsourcing Market Forecast to 2028

Global Drug Discovery Outsourcing Market Forecast to 2028

Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening

PUBLISHED: 16 April 2019
PAGES: 195
PRODUCT CODE: PHA0413

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The global drug discovery outsourcing market is estimated to have reach $22.69bn in 2018, dominated by the chemistry services segment. The global drug discovery outsourcing market is expected to grow at a CAGR of 11.7% in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 195-page report you will receive 114 charts– all unavailable elsewhere.

The 195-page report provides clear detailed insight into the global drug discovery outsourcing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Drug Discovery Outsourcing Market revenues forecasts to 2028

• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Service Type:
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification & Screening

• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Regional and National Market:
• North America: U.S, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
• LAMEA: Brazil, Saudi Arabia, Republic of South Africa, Rest of LAMEA

Global Drug Discovery Outsourcing Market Forecast to 2028

Each regional market is further segmented by submarket: chemistry services, biology services, lead optimisation, lead identification & screening.

• This report profiles and discusses the selected leading companies:
• Albany Molecular Research (AMRI)
• Aptuit, LLC
• Charles River Laboratories, Inc.
• Covance, Inc.
• Cyprotex plc
• Domainex
• Evotec AG
• GenScript
• IQVIA (QuintilesIMS)
• Laboratory Corporation of America
• Pharmaceutical Product Development (PPD)
• Selcia
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec

The report provides financial performance, service offerings, strategic moves & development, mergers & acquisitions.

• A SWOT analysis and Porter’s Five Forces Analysis of the Drug Discovery Outsourcing market.

• Key Questions Answered by this Report:
• How is the Drug Discovery Outsourcing Market evolving?
• What are the drivers and restraints for the growth of the Drug Discovery Outsourcing Market?
• How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• How will the market shares for each drug discovery outsourcing submarket develop to 2028?
• What is the value of the leading drug discovery outsourcing submarkets in important regions of the world?
• What will be the main driver for the overall market to 2028?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market by 2028?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Drug Discovery Outsourcing Market. You find data, trends and predictions.

Buy our report today Global Drug Discovery Outsourcing Market Forecast to 2028: Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Drug Discovery Outsourcing Market Forecast to 2028


Download sample pages

Complete the form below to download your free sample pages for Global Drug Discovery Outsourcing Market Forecast to 2028


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ